HiFiBiO Therapeutics, a multinational biotechnology company, has secured $75 million in Series D financing. Mirae Asset Financial Group led the round.
Source: Press Release
HiFiBiO grabs $75m Series D
HiFiBiO Therapeutics, a multinational biotechnology company, has secured $75 million in Series D financing.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: